137 related articles for article (PubMed ID: 6688679)
61. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
[TBL] [Abstract][Full Text] [Related]
62. Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials.
Noordijk EM; Carde P; Dupouy N; Hagenbeek A; Krol AD; Kluin-Nelemans JC; Tirelli U; Monconduit M; Thomas J; Eghbali H; Aleman BM; Bosq J; Vovk M; Verschueren TA; Pény AM; Girinsky T; Raemaekers JM; Henry-Amar M
J Clin Oncol; 2006 Jul; 24(19):3128-35. PubMed ID: 16754934
[TBL] [Abstract][Full Text] [Related]
63. Extended versus involved fields irradiation combined with MOPP chemotherapy in early clinical stages of Hodgkin's disease.
Zittoun R; Audebert A; Hoerni B; Bernadou A; Krulik M; Rojouan J; Eghbali H; Merle-Béral H; Parlier Y; Diebold J
J Clin Oncol; 1985 Feb; 3(2):207-14. PubMed ID: 3838188
[TBL] [Abstract][Full Text] [Related]
64. Hodgkin's disease in children: treatment with MOPP and low-dose, extended field irradiation without laparotomy. Late results and toxicity.
Jenkin D; Doyle J; Berry M; Blanchette V; Chan H; Doherty M; Freedman M; Greenberg M; Panzarella T; Saunders F
Med Pediatr Oncol; 1990; 18(4):265-72. PubMed ID: 2355885
[TBL] [Abstract][Full Text] [Related]
65. Comparison of total nodal irradiation versus combined sequence of mantle irradiation with mechlorethamine, vincristine, procarbazine, and prednisone in clinical stages I and II Hodgkin's disease: experience of the European Organization for Research and Treatment of Cancer.
Carde P; Hayat M; Cosset JM; Somers R; Burgers JM; Sizoo W; Meerwaldt JH; Hagenbeek A; Monconduit M; van der Schueren E
NCI Monogr; 1988; (6):303-10. PubMed ID: 3352775
[TBL] [Abstract][Full Text] [Related]
66. Massive mediastinal involvement in stage I-II Hodgkin's disease: response to combined modality treatment.
Zinzani PL; Mazza P; Gherlinzoni F; Bocchia M; Fiacchini M; Bendandi M; Barbieri E; Frezza G; Neri S; Aitini E
Leuk Lymphoma; 1992 Sep; 8(1-2):81-5. PubMed ID: 1493474
[TBL] [Abstract][Full Text] [Related]
67. [Late results of the treatment of advanced Hodgkin's disease by the MOPP/COPP programs (chlormethine or cyclophosphamide, vincristine, procarbazine and prednisone)].
Błasińska-Morawiec M; Płuzańska A; Krykowski E; Robak T; Mrówka I
Pol Arch Med Wewn; 1991 Oct; 86(4):274-80. PubMed ID: 1813880
[TBL] [Abstract][Full Text] [Related]
68. BCVPP chemotherapy for advanced Hodgkin's disease: evidence for greater duration of complete remission, greater survival, and less toxicity than with a MOPP regimen. Results of the Eastern Cooperative Oncology Group study.
Bakemeier RF; Anderson JR; Costello W; Rosner G; Horton J; Glick JH; Hines JD; Berard CW; DeVita VT
Ann Intern Med; 1984 Oct; 101(4):447-56. PubMed ID: 6089632
[TBL] [Abstract][Full Text] [Related]
69. [10 years' therapy of Hodgkin's disease in the Oncology Department of the Basel Canton Hospital: a retrospective study].
Battegay M; Obrist R; Obrecht JP
Onkologie; 1987 Oct; 10(5):308-11. PubMed ID: 3317173
[No Abstract] [Full Text] [Related]
70. The intergroup Hodgkin's disease in children. A study of stages I and II.
Gehan EA; Sullivan MP; Fuller LM; Johnston J; Kennedy P; Fryer C; Gilchrist GS; Hays DM; Hanson W; Heller R
Cancer; 1990 Mar; 65(6):1429-37. PubMed ID: 2407336
[TBL] [Abstract][Full Text] [Related]
71. Involved-field radiotherapy for advanced Hodgkin's lymphoma.
Aleman BM; Raemaekers JM; Tirelli U; Bortolus R; van 't Veer MB; Lybeert ML; Keuning JJ; Carde P; Girinsky T; van der Maazen RW; Tomsic R; Vovk M; van Hoof A; Demeestere G; Lugtenburg PJ; Thomas J; Schroyens W; De Boeck K; Baars JW; Kluin-Nelemans JC; Carrie C; Aoudjhane M; Bron D; Eghbali H; Smit WG; Meerwaldt JH; Hagenbeek A; Pinna A; Henry-Amar M;
N Engl J Med; 2003 Jun; 348(24):2396-406. PubMed ID: 12802025
[TBL] [Abstract][Full Text] [Related]
72. Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study.
Weiner MA; Leventhal B; Brecher ML; Marcus RB; Cantor A; Gieser PW; Ternberg JL; Behm FG; Wharam MD; Chauvenet AR
J Clin Oncol; 1997 Aug; 15(8):2769-79. PubMed ID: 9256118
[TBL] [Abstract][Full Text] [Related]
73. CCNU, vinblastine, procarbazine and prednisone (CVPP) with extended-field radiotherapy in the treatment of early unfavorable Hodgkin's disease. A prospective study on behalf of the Gruppo Italiano per lo Studio dei Linfomi (GISL).
Gobbi PG; Pieresca C; Cavanna L; Corbella F; Vallisa D; Federico M; Formisano R; Carotenuto M; Merli F; Callea V; Angrilli F; Silingardi V
Haematologica; 1996; 81(6):503-12. PubMed ID: 9009437
[TBL] [Abstract][Full Text] [Related]
74. Extended-field radiotherapy in favorable stage IA-IIA Hodgkin's disease (prognostic role of stage).
Zanini M; Viviani S; Santoro A; Soncini F; Bonfante V; Devizzi L; Villani F; Castellani MR; Negretti E; Zucali R
Int J Radiat Oncol Biol Phys; 1994 Nov; 30(4):813-9. PubMed ID: 7525516
[TBL] [Abstract][Full Text] [Related]
75. Hodgkin's disease in children: correlation of clinical characteristics, staging procedures, and treatment at the University of Minnesota.
McClain KL; Heise R; Day DL; Lee CK; Woods WG; Aeppli D
Am J Pediatr Hematol Oncol; 1990; 12(2):147-54. PubMed ID: 1696073
[TBL] [Abstract][Full Text] [Related]
76. Stage IA-IIB Hodgkin's disease: management and outcome of extensive thoracic involvement.
Hughes-Davies L; Tarbell NJ; Coleman CN; Silver B; Shulman LN; Linggood R; Canellos GP; Mauch PM
Int J Radiat Oncol Biol Phys; 1997 Sep; 39(2):361-9. PubMed ID: 9308940
[TBL] [Abstract][Full Text] [Related]
77. Radiotherapy versus combined modality treatment of stage I and II Hodgkin's disease.
Nissen NI; Nordentoft AM
Cancer Treat Rep; 1982 Apr; 66(4):799-803. PubMed ID: 7074650
[TBL] [Abstract][Full Text] [Related]
78. MOPP therapy in children with Hodgkin's disease.
Madanat FF
Am J Pediatr Hematol Oncol; 1989; 11(4):407-10. PubMed ID: 2618974
[TBL] [Abstract][Full Text] [Related]
79. Combination chemotherapy plus low-dose involved-field radiotherapy for early clinical stage Hodgkin's lymphoma.
Vassilakopoulos TP; Angelopoulou MK; Siakantaris MP; Kontopidou FN; Dimopoulou MN; Kokoris SI; Kyrtsonis MC; Tsaftaridis P; Karkantaris C; Anargyrou K; Boutsis DE; Variamis E; Michalopoulos T; Boussiotis VA; Panayiotidis P; Papavassiliou C; Pangalis GA
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):765-81. PubMed ID: 15183480
[TBL] [Abstract][Full Text] [Related]
80. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ
Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
